This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
Anglo American (AAL.L) – Copper output rose 18% to 202,000 tns, raised output guidance to 710,000-730,000 tns from 700,000-720,000. Iron Ore output totalled 11.3m tns up 10% from last year. Platinum production fell 39% to 357,000 oz due to a strike in South Africa and lowers its guidance to 2.1m oz from 2.3-2.4m oz. Closing Price 1547.00p (Reuters)
ARM Holdings (ARM.L) – Apple’s second-quarter revenue and profit exceeded analysts’ estimates amid a surge in iPhone sales. Closing Price 956.00p (Bloomberg)
AstraZeneca (AZN.L) - Progress with a new generation of cancer drugs. Posted a 17% fall in core EPS on Thursday. No reference to a reported £60bn bid approach from Pfizer. Reiterated that 2014 sales were likely to fall by a low-to-mid single digit percentage figure. Sales in the first quarter were flat at $6.42bn vs. $6.37bn expected. Closing price 4042.50p. (Reuters)
Travis Perkins (TPK.L) – Q1 total sales growth of 15.6%, 14.2% on a comparable trading days basis. Q1 like-for-like sales growth of 12.7%, 2 year like-for-like sales growth of 9.3%.Closing Price 1832.00p (Bloomberg)
Unilever (ULVR.L) – Revenue fell 6.3% to €11.4bn, though underlying sales, which exclude the impact of foreign exchange and acquisitions and disposals, rose 3.6%. Closing Price 2636.00p (Reuters)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| Associated British Foods | ABF.L | 8.82% | 9.92% | 3.97% |
| ARM Holdings | ARM.L | -2.74% | -0.91% | -4.11% |
| Fenner | FENR.L | 6.41% | 6.62% | -1.28% |
| Petra Diamonds | PDL.L | 2.85% | 4.84% | -0.73% |
| Sports Direct International | SPD.L | -3.98% | 0.60% | -4.75% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research